{"id":"https://openalex.org/W7120762333","doi":null,"title":"Development and in vitro biological evaluation of nanostructured systems containing a new organoselenium compound: different technological approaches aiming the sensitization of resistant tumor cells","display_name":"Development and in vitro biological evaluation of nanostructured systems containing a new organoselenium compound: different technological approaches aiming the sensitization of resistant tumor cells","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-28","ids":{"openalex":"https://openalex.org/W7120762333"},"language":"pt","primary_location":{"id":"pmh:oai:repositorio.ufsm.br:1/29331","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufsm.br/handle/1/29331","pdf_url":"http://repositorio.ufsm.br/bitstream/1/29331/1/TES_PPGCF_2023_MACEDO_LETICIA.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFSM","raw_type":"info:eu-repo/semantics/doctoralThesis"},"parent_works":[],"lineage":["https://openalex.org/W7120762333"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://repositorio.ufsm.br/bitstream/1/29331/1/TES_PPGCF_2023_MACEDO_LETICIA.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046281097","display_name":"Let\u00edcia Bueno Macedo","orcid":"https://orcid.org/0000-0003-1333-1522","observed_orcids":["https://orcid.org/0000-0003-1333-1522"]},"institutions":[{"id":"https://openalex.org/I33501960","display_name":"Universidade Federal de Santa Maria","ror":"https://ror.org/01b78mz79","country_code":"BR","type":"education","lineage":["https://openalex.org/I33501960"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Macedo, Let\u00edcia Bueno","raw_affiliation_strings":["Departamento de Qu\u00edmica , Universidade Federal de Santa Maria , Av. Roraima 1000 , 97105- 900 Santa Maria , RS , Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Qu\u00edmica , Universidade Federal de Santa Maria , Av. Roraima 1000 , 97105- 900 Santa Maria , RS , Brazil","institution_ids":["https://openalex.org/I33501960"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5046281097"],"corresponding_institution_ids":["https://openalex.org/I33501960"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/organoselenium-compounds","display_name":"organoselenium compounds","score":0.9520000219345093},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.8349999785423279},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.8560000061988831},{"id":"https://openalex.org/keywords/plga","display_name":"PLGA","score":0.8579999804496765},{"id":"https://openalex.org/keywords/ph-sensitive-nanoparticles","display_name":"pH-responsive nanoparticles","score":0.5170000195503235},{"id":"https://openalex.org/keywords/transferrin-targeting","display_name":"transferrin targeting","score":0.6850000023841858},{"id":"https://openalex.org/keywords/active-targeting","display_name":"active targeting","score":0.5799999833106995},{"id":"https://openalex.org/keywords/drug-encapsulation","display_name":"drug encapsulation","score":0.6150000095367432},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.574999988079071},{"id":"https://openalex.org/keywords/hemocompatibility","display_name":"hemocompatibility","score":0.9440000057220459},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.6809999942779541},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7260000109672546},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.8799999952316284},{"id":"https://openalex.org/keywords/three-dimensional-tumor-models","display_name":"3D tumor models","score":0.6110000014305115},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.3400000035762787},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6815000176429749},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5870000123977661},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.5712000131607056},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5282999873161316},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5041000247001648},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4887999892234802},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45719999074935913},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4260999858379364},{"id":"https://openalex.org/C2779902561","wikidata":"https://www.wikidata.org/wiki/Q471706","display_name":"Hemolysis","level":2,"score":0.4156000018119812},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.4018000066280365},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.38769999146461487},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.36970001459121704},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.3490000069141388},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.3483999967575073},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.34599998593330383},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.31869998574256897},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3156000077724457},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.3124000132083893},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.30219998955726624},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.29899999499320984},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.29580000042915344},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.2838999927043915},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.2809000015258789},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.2745000123977661},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.272599995136261},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.27079999446868896},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2583000063896179},{"id":"https://openalex.org/C181674461","wikidata":"https://www.wikidata.org/wiki/Q5731621","display_name":"Hep G2","level":3,"score":0.2583000063896179}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.ufsm.br:1/29331","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufsm.br/handle/1/29331","pdf_url":"http://repositorio.ufsm.br/bitstream/1/29331/1/TES_PPGCF_2023_MACEDO_LETICIA.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFSM","raw_type":"info:eu-repo/semantics/doctoralThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.ufsm.br:1/29331","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufsm.br/handle/1/29331","pdf_url":"http://repositorio.ufsm.br/bitstream/1/29331/1/TES_PPGCF_2023_MACEDO_LETICIA.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"instacron:UFSM","raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G29316538","display_name":null,"funder_award_id":"(Code 001)","funder_id":"https://openalex.org/F4320321091","funder_display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior"}],"funders":[{"id":"https://openalex.org/F4320321091","display_name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","ror":"https://ror.org/00x0ma614"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7120762333.pdf","grobid_xml":"https://content.openalex.org/works/W7120762333.grobid-xml"},"referenced_works_count":154,"referenced_works":["https://openalex.org/W88431272","https://openalex.org/W1172187033","https://openalex.org/W1490243144","https://openalex.org/W1581483685","https://openalex.org/W1790783162","https://openalex.org/W1869406861","https://openalex.org/W1953531402","https://openalex.org/W1965975485","https://openalex.org/W1969024311","https://openalex.org/W1972154409","https://openalex.org/W1974169241","https://openalex.org/W1976041621","https://openalex.org/W1976833185","https://openalex.org/W1977718036","https://openalex.org/W1978418561","https://openalex.org/W1983176088","https://openalex.org/W1985781888","https://openalex.org/W1988318590","https://openalex.org/W1995400766","https://openalex.org/W1996595845","https://openalex.org/W1996697333","https://openalex.org/W1997308573","https://openalex.org/W2002587663","https://openalex.org/W2005271397","https://openalex.org/W2008564265","https://openalex.org/W2012991711","https://openalex.org/W2013478683","https://openalex.org/W2015346163","https://openalex.org/W2016543419","https://openalex.org/W2020398834","https://openalex.org/W2020876696","https://openalex.org/W2022981155","https://openalex.org/W2030873172","https://openalex.org/W2032374968","https://openalex.org/W2033468145","https://openalex.org/W2036247492","https://openalex.org/W2036459378","https://openalex.org/W2036948210","https://openalex.org/W2036986058","https://openalex.org/W2063264712","https://openalex.org/W2063802697","https://openalex.org/W2070932895","https://openalex.org/W2072997205","https://openalex.org/W2073345376","https://openalex.org/W2074471984","https://openalex.org/W2079189662","https://openalex.org/W2080913348","https://openalex.org/W2087032263","https://openalex.org/W2087975548","https://openalex.org/W2116606676","https://openalex.org/W2117165478","https://openalex.org/W2128635872","https://openalex.org/W2135215951","https://openalex.org/W2135782311","https://openalex.org/W2137634849","https://openalex.org/W2138298775","https://openalex.org/W2139107535","https://openalex.org/W2147458973","https://openalex.org/W2153887608","https://openalex.org/W2161946327","https://openalex.org/W2162154830","https://openalex.org/W2179281062","https://openalex.org/W2216824414","https://openalex.org/W2225980581","https://openalex.org/W2231176282","https://openalex.org/W2276560545","https://openalex.org/W2283197772","https://openalex.org/W2294386056","https://openalex.org/W2302704900","https://openalex.org/W2313688287","https://openalex.org/W2314480510","https://openalex.org/W2314769705","https://openalex.org/W2329049989","https://openalex.org/W2461033802","https://openalex.org/W2511343918","https://openalex.org/W2542816041","https://openalex.org/W2546877935","https://openalex.org/W2549858084","https://openalex.org/W2560423638","https://openalex.org/W2563965704","https://openalex.org/W2564808742","https://openalex.org/W2576777368","https://openalex.org/W2600452401","https://openalex.org/W2607295926","https://openalex.org/W2608213513","https://openalex.org/W2614727044","https://openalex.org/W2735580466","https://openalex.org/W2740226484","https://openalex.org/W2741141829","https://openalex.org/W2756856565","https://openalex.org/W2769426045","https://openalex.org/W2788364246","https://openalex.org/W2795537524","https://openalex.org/W2802809487","https://openalex.org/W2883696242","https://openalex.org/W2889344199","https://openalex.org/W2897584777","https://openalex.org/W2899503349","https://openalex.org/W2901562359","https://openalex.org/W2906302439","https://openalex.org/W2908554896","https://openalex.org/W2908977804","https://openalex.org/W2909330821","https://openalex.org/W2910346583","https://openalex.org/W2911346422","https://openalex.org/W2912766984","https://openalex.org/W2913207981","https://openalex.org/W2923643133","https://openalex.org/W2939209705","https://openalex.org/W2942324106","https://openalex.org/W2947004672","https://openalex.org/W2953713098","https://openalex.org/W2955569956","https://openalex.org/W2965318563","https://openalex.org/W2972802464","https://openalex.org/W2974103503","https://openalex.org/W2982103792","https://openalex.org/W2990297243","https://openalex.org/W2999271086","https://openalex.org/W3000448813","https://openalex.org/W3005521705","https://openalex.org/W3010948416","https://openalex.org/W3010953899","https://openalex.org/W3011159327","https://openalex.org/W3021909056","https://openalex.org/W3024251273","https://openalex.org/W3025080581","https://openalex.org/W3025538385","https://openalex.org/W3043787700","https://openalex.org/W3049495358","https://openalex.org/W3092057003","https://openalex.org/W3128646645","https://openalex.org/W3129058300","https://openalex.org/W3130911881","https://openalex.org/W3133304393","https://openalex.org/W3135842759","https://openalex.org/W3138289793","https://openalex.org/W3144585809","https://openalex.org/W3161203366","https://openalex.org/W3163067523","https://openalex.org/W3164577482","https://openalex.org/W3196058432","https://openalex.org/W3202229075","https://openalex.org/W3216713526","https://openalex.org/W4200253115","https://openalex.org/W4200469555","https://openalex.org/W4214917511","https://openalex.org/W4229712505","https://openalex.org/W4282031654","https://openalex.org/W4283268012","https://openalex.org/W4283383104","https://openalex.org/W4304084233","https://openalex.org/W4310225317","https://openalex.org/W4324285182"],"related_works":["https://openalex.org/W4200253115","https://openalex.org/W4392656075","https://openalex.org/W4395685198","https://openalex.org/W7120610225","https://openalex.org/W4402634926","https://openalex.org/W7220358287","https://openalex.org/W7117681999","https://openalex.org/W4410709600","https://openalex.org/W2970719010","https://openalex.org/W2969487474"],"abstract_inverted_index":{"Cancer":[0],"is":[1,73],"one":[2],"of":[3,7,18,54,68,82,96,117,131,211,268,289,299,337,361],"the":[4,19,29,52,66,80,83,93,115,128,142,150,163,183,209,214,259,265,290,307,311,323,341,345,352],"major":[5],"causes":[6],"mortality":[8],"worldwide":[9],"and":[10,25,37,103,193,202,226,253,276,282,332,351],"has":[11],"become":[12],"a":[13,61,74,147,168,229,296,328,334],"public":[14],"health":[15],"problem.":[16],"Most":[17],"conventional":[20],"cancer":[21],"treatments":[22],"are":[23,89,355],"nonspecific":[24],"do":[26],"not":[27],"target":[28],"tumor":[30,255,284,300,324],"cells":[31,36],"only,":[32],"also":[33,293,319],"affecting":[34],"healthy":[35],"leading":[38],"to":[39,91,126,182,232,243,321,358],"systemic":[40],"toxicity":[41,102],"associated":[42,348],"with":[43,58,167,173,262,272,349],"serious":[44],"side":[45],"effects.":[46],"Few":[47],"studies":[48],"have":[49],"shown":[50],"that":[51,77,208,221,241,344],"development":[53],"nucleoside":[55,156],"analogues":[56],"modified":[57,166],"organochalcogens":[59],"present":[60,224],"promising":[62,75,356],"antitumor":[63,69,129,238,266,287],"activity.":[64,217],"Additionally,":[65,264],"encapsulation":[67],"drugs":[70],"in":[71,236,251,280,304],"nanoparticles":[72,139],"approach":[76],"may":[78],"enhance":[79,359],"efficacy":[81,130,360],"currently":[84],"chemotherapy":[85],"drugs.":[86],"These":[87],"systems":[88],"able":[90,320],"improve":[92],"therapeutic":[94,105],"index":[95,106],"various":[97],"drugs,":[98],"improving":[99],"efficacy,":[100],"reducing":[101],"achieving":[104],"for":[107,149,258],"an":[108,153],"extended":[109],"period.":[110],"Moreover,":[111],"some":[112],"approaches":[113,357],"as":[114,146,303],"use":[116],"pH-sensitive":[118,169,230],"adjuvants":[119],"or":[120],"active":[121],"targeting":[122],"can":[123],"be":[124],"used":[125],"increase":[127],"nanocarriers.":[132],"In":[133],"this":[134],"sense,":[135],"we":[136],"prepared":[137],"polymeric":[138],"(NPs)":[140],"using":[141,295],"polymer":[143],"poly-lactic-co-glycolic":[144],"acid":[145],"carrier":[148],"5\u2019-Se-(phenyl)-3-(amino)-thymidine":[151],"(ACAT-Se),":[152],"organoselenium":[154],"compound,":[155],"analogue,":[157],"synthesized":[158],"from":[159],"zidovudine":[160],"(3-azidothymidine).":[161],"Firstly,":[162],"NPs":[164,190,223,244,260,291,317],"were":[165,191,318],"adjuvant":[170],"(lysine-based":[171],"surfactant":[172],"litium":[174],"counterion,":[175],"77KL)":[176],"(NP":[177,187],"1)":[178],"and,":[179,302],"then,":[180],"conjugated":[181,261],"biomarker":[184],"transferrin":[185],"(Tf)":[186],"2).":[188],"The":[189,235,286,315],"characterized":[192],"presented":[194,277,327],"adequate":[195],"physicochemical":[196],"characteristics.":[197],"Furthermore,":[198],"DPPH":[199],"(1-1-diphenyl-2-":[200],"picrylhydrazyl)":[201],"ABTS":[203],"(2,2\u2032-azinobis-(3-ethylbenzothiazoline-6-sulfonic":[204],"acid))":[205],"assays":[206,239],"suggest":[207],"nanoencapsulation":[210],"ACAT-Se":[212],"increased":[213],"compound":[215,250],"antioxidant":[216],"Hemolysis":[218],"assay":[219],"indicate":[220,343],"both":[222],"hemocompatibility,":[225],"77KL":[227],"provide":[228],"behavior":[231],"NP":[233,269,308,346,353],"1.":[234],"vitro":[237],"demonstrated":[240],"ACAT-Se-loaded":[242],"induced":[245,333],"higher":[246,329],"cytotoxicity":[247],"than":[248],"free":[249],"sensitive":[252,281],"resistant":[254,283],"cells,":[256],"especially":[257],"Tf.":[263],"activity":[267,288],"1":[270],"combined":[271],"doxorubicin":[273],"was":[274,292,310],"study":[275],"synergistic":[278],"interaction":[279],"cells.":[285],"assessed":[294],"3D":[297],"model":[298],"spheroids":[301],"2D":[305],"model,":[306],"2":[309],"most":[312],"cytotoxic":[313],"treatment.":[314],"Tf-decorated":[316],"inhibit":[322],"cell":[325,330],"migration,":[326],"internalization":[331],"greater":[335],"number":[336],"apoptotic":[338],"events.":[339],"Therefore,":[340],"results":[342],"1,":[347],"doxorubicin,":[350],"2,":[354],"antineoplastic":[362],"therapy.":[363]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7120762333","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-01-10T00:00:00"}
